Literature DB >> 13864563

Clinical trial with desmethylimipramine (G-35020), a new antidepressive compound.

T A BAN, H E LEHMANN.   

Abstract

Entities:  

Keywords:  DEPRESSION/therapy; IMIPRAMINE/related compounds

Mesh:

Substances:

Year:  1962        PMID: 13864563      PMCID: PMC1849076     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  5 in total

1.  On the mechanism of antidepressant action of imipraminelike drugs.

Authors:  F SULSER; J WATTS; B B BRODIE
Journal:  Ann N Y Acad Sci       Date:  1962-01-13       Impact factor: 5.691

2.  N(gamma-Methylaminopropyl) iminodibenzyl: a new antidepressant. Preliminary report.

Authors:  L J MEDUNA; L G ABOOD; J H BIEL
Journal:  J Neuropsychiatr       Date:  1961-06

3.  Therapeutic trial of iproniazid (marsilid) in depressed and apathetic patients.

Authors:  R L DEVERTEUIL; H E LEHMANN
Journal:  Can Med Assoc J       Date:  1958-01-15       Impact factor: 8.262

4.  New drugs in psychiatric therapy.

Authors:  H E LEHMANN
Journal:  Can Med Assoc J       Date:  1961-11-18       Impact factor: 8.262

5.  Preliminary pharmacological and clinical results with desmethylimipramine (DMI) G 35020, a metabolite of imipramine.

Authors:  B BRODIE; P DICK; P KIELHOLZ; W POELDINGER; W THEOBALD
Journal:  Psychopharmacologia       Date:  1961-12-19
  5 in total
  3 in total

1.  PSYCHOPHARMACOLOGY OF IMIPRAMINE AND DESIPRAMINE: A COMPARATIVE STUDY OF THEIR EFFECTS IN NORMAL MALES.

Authors:  A DIMASCIO; G HENINGER; G L KLERMAN
Journal:  Psychopharmacologia       Date:  1964-04-03

2.  [DESIPRAMINE (PERTOFRAN) IN THE TREATMENT OF DEPRESSIONS WITH A PSYCHODYNAMIC ANALYSIS OF ITS THERAPEUTIC EFFECTS].

Authors:  R ALNAES; J KRISTIANSEN
Journal:  Arch Psychiatr Nervenkr       Date:  1964-03-16

3.  The Desmethyl Metabolite of Imipramine (G-35020) in the Treatment of Depression: Further Clinical Experience.

Authors:  A M Mann; G F Heseltine
Journal:  Can Med Assoc J       Date:  1963-06-01       Impact factor: 8.262

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.